LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:
Conference: Stifel Healthcare Conference
Location: New York, NY
Date: Tuesday, November 19, 2024
Presentation: 8:35 a.m. ET
Speakers: Curt R. Hartman, President and Chief Executive Officer, and Nate Miersma, Vice President and General Manager, U.S. Orthopedics
Conference: Jefferies London Healthcare Conference
Location: London, UK
Date: Wednesday, November 20, 2024
Presentation: 11:00 a.m. GMT (6:00 a.m. ET)
Speakers: Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer
A live webcast of each fireside chat will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the events.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and associated webcasts may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
